Acrivon Therapeutics, Inc. (ACRV)

NASDAQ: ACRV · IEX Real-Time Price · USD

7.33

-0.23 (-3.04%)

At close: Jul 19, 2024, 4:00 PM

7.32

-0.01 (-0.14%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Acrivon Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	226	109	241	-
Market Cap Growth	-41.82%	-54.61%	-	-
Enterprise Value	120	-14	117	-94
PE Ratio	-	-1.81	-7.72	-
PB Ratio	2.10	0.90	1.41	-
P/FCF Ratio	-3.21	-2.49	-7.45	-
P/OCF Ratio	-3.35	-2.56	-7.99	-
EV/EBITDA Ratio	-0.89	0.24	-3.90	6.12
EV/EBIT Ratio	-0.87	0.23	-3.77	5.81
EV/FCF Ratio	-1.11	0.32	-3.64	6.64
Debt / Equity Ratio	0.04	0.04	0.03	-0.24
Debt / EBITDA Ratio	-0.07	-0.08	-0.16	-0.37
Debt / FCF Ratio	-0.09	-0.11	-0.15	-0.40
Quick Ratio	12.21	9.61	19.67	34.31
Current Ratio	12.40	9.75	20.27	34.46
Return on Equity (ROE)	-49.70%	-42.50%	-42.50%	100.80%
Return on Assets (ROA)	-45.00%	-39.00%	-21.70%	-29.90%
Return on Capital (ROIC)	-62.60%	-53.32%	-18.61%	89.02%
Earnings Yield	-28.33%	-55.30%	-12.95%	-
FCF Yield	-22.29%	-40.23%	-13.42%	-
Buyback Yield / Dilution	-3.06%	-435.63%	-136.43%	-21.70%
Total Shareholder Return	-3.06%	-435.63%	-136.43%	-21.70%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).